tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Argenx downgraded to Hold from Buy at Deutsche Bank
PremiumThe FlyArgenx downgraded to Hold from Buy at Deutsche Bank
12d ago
Deutsche Bank downgrades Argenx to Hold after greater than 40% rally
Premium
The Fly
Deutsche Bank downgrades Argenx to Hold after greater than 40% rally
12d ago
Argenx’s Phase 3 Study on Efgartigimod: A Potential Game-Changer in Autoimmune Treatment
Premium
Company Announcements
Argenx’s Phase 3 Study on Efgartigimod: A Potential Game-Changer in Autoimmune Treatment
16d ago
Argenx’s Pediatric gMG Study: A Potential Game-Changer in Rare Disease Treatment
PremiumCompany AnnouncementsArgenx’s Pediatric gMG Study: A Potential Game-Changer in Rare Disease Treatment
16d ago
Argenx’s Promising Phase 3 Study on Efgartigimod IV for ITP: A Potential Game-Changer
Premium
Company Announcements
Argenx’s Promising Phase 3 Study on Efgartigimod IV for ITP: A Potential Game-Changer
16d ago
Argenx’s Efgartigimod Study: A Potential Game-Changer for Ocular Myasthenia Gravis
Premium
Company Announcements
Argenx’s Efgartigimod Study: A Potential Game-Changer for Ocular Myasthenia Gravis
16d ago
Argenx price target raised to $887 from $880 at BofA
PremiumThe FlyArgenx price target raised to $887 from $880 at BofA
21d ago
Argenx’s Vyvgart Expansion and Pipeline Strength Bolster Buy Rating
Premium
Ratings
Argenx’s Vyvgart Expansion and Pipeline Strength Bolster Buy Rating
21d ago
Argenx Se’s Vyvgart Gains Momentum with Successful Phase 3 Results and Market Expansion Potential
Premium
Ratings
Argenx Se’s Vyvgart Gains Momentum with Successful Phase 3 Results and Market Expansion Potential
26d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100